Women of childbearing age and valproate: From inertia to window dressing

Corfe-Tan J McLay L Mentzel C . Prescription of sodium valproate to women of childbearing potential in southern district mental health services in New Zealand. Australas Psychiatr 2023: 10398562231197286. online Aug 25.

Braillon A Martin M . Comment on: “Proposals for engaging patients and healthcare professionals in risk minimisation from an analysis of stakeholder input to the EU valproate assessment using the novel analysing stakeholder safety engagement tool (ASSET)”. Drug Saf 2021; 44: 1007–1009.

Martin M Hill C Bewley S , et al.. Transgenerational adverse effects of valproate? A patient report from 90 affected families. Birth Defects Res 2022; 114: 13–16.

New Zealand Medicines and Medical Devices Safety Authority . Safety Information. Sodium valproate (Epilim) use in people who can father children: important new safety information, 2023. Available at https://www.medsafe.govt.nz/safety/Alerts/Sodium_valproate_Epilim_use_in_people_who_can_father_children.aspAccessed28June2023 (Accessed 9 September 2023.

Ibi D Fujiki Y Koide N , et al.. Paternal valproic acid exposure in mice triggers behavioral alterations in offspring. Neurotoxicol Teratol 2019; 76: 106837.